A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers
Recruiting
Observational Study
Hepatocholangiocarcinoma
Fibrolamellar Carcinoma
Hepatic Epithelioid Hemangioendothelioma
Hepatoblastoma
Hepatic Neuroendocrine Carcinoma
Hepatic Carcinosarcomas
Hepatic Cystadenoma
Hepatic Leiomyosarcomas
Hepatic Angiosarcomas
Cholangiocarcinoma
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 150 (estimated)
- Sponsor
- Federation Francophone de Cancerologie Digestive · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of this French multicenter retrospective study is to describ rare primary hepatic cancers clinical, histological and radiological features, to obtain a biological tumor and blood collection, and to evaluate the efficacy of treatments received in clinical practice in order to determine optimal therapeutic sequences. This retrospective cohort will be the backbone of future translational stud…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 18 years of age or older,
* with histologically proven hepato-cholangiocarcinoma, fibrolamellar hepatocellular carcinoma, epithelioid hemangioendothelioma or hepatic angiosarcoma
* diagnosed after January 01, 2018 living or deceased at the time of registration in the cohort
* …
Contacts